Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
Krisstina Gowin, Clinical Associate Professor at City of Hope, shared a post on LinkedIn:
“Could the gut microbiome be one of the most important—and most overlooked—factors influencing outcomes in hematology?
In our latest ASH Clinical News guest commentary, Dr. Urvi Shah and I explore the growing evidence that the gut microbiome plays a critical role in allogeneic stem cell transplantation and CAR T-cell therapy.
Emerging data suggest that microbial diversity, short-chain fatty acids, bile acid metabolism, dietary patterns, and even antibiotic exposure can influence treatment response, toxicity, graft-versus-host disease, and survival.
As hematologists, we meticulously optimize conditioning regimens, chemotherapy dosing, and supportive care. It may be time to bring microbiome health into that same conversation.
Key takeaways:
- Microbial diversity is associated with improved transplant outcomes.
- Fiber-rich, plant-forward dietary patterns support beneficial microbiome composition and metabolite production.
- Broad-spectrum anti-anaerobic antibiotics may adversely affect outcomes in both alloHCT and CAR T-cell therapy.
- The microbiome is emerging as a powerful biomarker and potential therapeutic target in hematology.
The future of hematology may not only depend on understanding the cancer and the immune system—but also the trillions of microbes that help shape both.
Thank you to my co-authors and collaborators, Dr. Urvi Shah, Dr. Jenny Paredes, and Dr. Marcel van den Brink, for advancing this exciting field.
Read the full article on ASH Clinical News.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI